CIMG Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending March 31, 2026. The company generated revenues of $3.2 million during the quarter, a notable increase from zero revenue in the same period last year. For the six months ending March 31, 2026, total revenues reached $19 million, compared to $22,853 in the prior year, marking an increase of over 82,969%. This growth is attributed to the successful sales of its Maca product line and the introduction of new offerings in the Homology of Medicine and Food Series, as well as the Computing Power Product Series.
Despite the revenue growth, CIMG Inc. reported a net loss of $15.4 million for the quarter, a substantial increase from a loss of $385,556 in the same quarter of 2025. The six-month net loss also rose to $34.9 million from $1.9 million in the previous year. The increase in losses is primarily due to rising labor costs, professional fees, and significant fair value adjustments related to digital assets, particularly Bitcoin, which the company holds.
Operationally, CIMG Inc. has undergone strategic changes, including a shift in focus from specialty coffee products to a broader range of health and wellness offerings. The company has expanded its distribution channels in Asia and launched several new product lines, including Maca-enhanced foods and beverages. As of March 31, 2026, the company reported holding 730 Bitcoin valued at approximately $49.8 million, although this figure is subject to market volatility. The company’s total assets decreased to $53.2 million from $74.2 million in the previous fiscal period, largely due to a reduction in cash and inventory levels.
CIMG Inc. has also faced challenges, including a suspension of trading on Nasdaq due to non-compliance with listing rules, leading to its current quotation on the OTC market under the symbol "CIMG." The company is actively seeking additional funding to support its operations, as it reported a cash balance of only $17,025 as of the end of the reporting period. Management has indicated that it plans to raise capital through equity or debt financing to address its liquidity needs and continue its business operations.
Looking ahead, CIMG Inc. remains focused on expanding its product offerings and market presence, particularly in Asia. The company aims to leverage its digital marketing strategies and technological advancements to enhance sales and distribution capabilities. However, the ongoing financial losses and the need for additional capital raise concerns about its ability to continue as a going concern in the near future.
About CIMG Inc.
CIMG Inc. is a Nevada-incorporated company focused on sourcing, marketing, and distributing maca-based health and wellness products across Asia and beyond. Its core offerings include dietary supplements, functional foods, and beverages like maca peptide coffee, maca wine, and energy drinks. The company leverages digital marketing, strategic distribution channels, and sustainable sourcing to serve wholesale and retail markets, emphasizing quality, innovation, and global expansion in the natural superfood industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.